Orthocell Ltd ( (AU:OCC) ) has shared an announcement.
Orthocell Ltd announced the issuance of 100,000 ordinary fully paid shares under its Employee Incentive Plan, with the shares set to be quoted on the Australian Securities Exchange (ASX) on March 3, 2025. This move is part of the company’s strategy to incentivize employees, potentially enhancing its operational performance and industry positioning.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine. The company primarily develops and commercializes products for the repair and regeneration of soft tissue injuries, with a market focus on innovative medical solutions.
YTD Price Performance: -4.43%
Average Trading Volume: 1,799,878
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$313.2M
See more data about OCC stock on TipRanks’ Stock Analysis page.